Literature DB >> 7906035

Research note: avidity of chicken yolk antibodies to enterotoxigenic Escherichia coli fimbriae.

Y Ikemori1, R C Peralta, M Kuroki, H Yokoyama, Y Kodama.   

Abstract

The yolk antibodies from chickens and the serum and colostrum antibodies from cows were obtained after immunization of these animals with inactivated bacterin or purified K99 fimbriae from enterotoxigenic Escherichia coli (ETEC). The avidity of anti-K99 fimbriae antibodies produced from either chickens or cows was measured by competitive binding assay of ELISA. The yolk antibodies competed strongly with the serum and colostrum antibodies from immunized cows and inhibited 40 to 80% of the binding of these antibodies. Results demonstrate that the avidity of antibodies obtained from immunized chickens compares with that obtained from immunized cows. Thus, the yolk antibody from immunized chickens, aside from its use for prophylaxis against some infectious diseases, may also serve as effective ligand for purification of biologically active substances such as fimbrial antigens by affinity chromatographic procedures.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7906035     DOI: 10.3382/ps.0722361

Source DB:  PubMed          Journal:  Poult Sci        ISSN: 0032-5791            Impact factor:   3.352


  10 in total

Review 1.  Oral passive IgY-based immunotherapeutics: a novel solution for prevention and treatment of alimentary tract diseases.

Authors:  Shofiqur Rahman; Sa Van Nguyen; Faustino C Icatlo; Kouji Umeda; Yoshikatsu Kodama
Journal:  Hum Vaccin Immunother       Date:  2013-01-14       Impact factor: 3.452

2.  Chicken Egg Yolk Antibodies (IgY) for Prophylaxis and Treatment of Rotavirus Diarrhea in Human and Animal Neonates: A Concise Review.

Authors:  Hlaing Myat Thu; Theingi Win Myat; Mo Mo Win; Kyaw Zin Thant; Shofiqur Rahman; Kouji Umeda; Sa Van Nguyen; Faustino C Icatlo; Kyoko Higo-Moriguchi; Koki Taniguchi; Takao Tsuji; Keiji Oguma; Sang Jong Kim; Hyun Suk Bae; Hyuk Joon Choi
Journal:  Korean J Food Sci Anim Resour       Date:  2017-02-28       Impact factor: 2.622

Review 3.  IgY antibodies for the immunoprophylaxis and therapy of respiratory infections.

Authors:  Aymn Talat Abbas; Sherif Aly El-Kafrawy; Sayed Sartaj Sohrab; Esam Ibraheem Ahmed Azhar
Journal:  Hum Vaccin Immunother       Date:  2018-09-19       Impact factor: 3.452

Review 4.  Phage display: a powerful technology for the generation of high specificity affinity reagents from alternative immune sources.

Authors:  William J J Finlay; Laird Bloom; Orla Cunningham
Journal:  Methods Mol Biol       Date:  2011

5.  Passive protection of neonatal calves against bovine coronavirus-induced diarrhea by administration of egg yolk or colostrum antibody powder.

Authors:  Y Ikemori; M Ohta; K Umeda; F C Icatlo; M Kuroki; H Yokoyama; Y Kodama
Journal:  Vet Microbiol       Date:  1997-11       Impact factor: 3.293

6.  Phage Display: A Powerful Technology for the Generation of High-Specificity Affinity Reagents from Alternative Immune Sources.

Authors:  William J J Finlay; Laird Bloom; Joanne Grant; Edward Franklin; Deirdre Ní Shúilleabháin; Orla Cunningham
Journal:  Methods Mol Biol       Date:  2017

7.  Anti-S1 MERS-COV IgY Specific Antibodies Decreases Lung Inflammation and Viral Antigen Positive Cells in the Human Transgenic Mouse Model.

Authors:  Aymn T Abbas; Sherif A El-Kafrawy; Sayed Sartaj Sohrab; Ashraf A Tabll; Ahmed M Hassan; Naoko Iwata-Yoshikawa; Noriyo Nagata; Esam I Azhar
Journal:  Vaccines (Basel)       Date:  2020-11-01

8.  Immunotherapeutic Efficacy of IgY Antibodies Targeting the Full-Length Spike Protein in an Animal Model of Middle East Respiratory Syndrome Coronavirus Infection.

Authors:  Sherif A El-Kafrawy; Aymn T Abbas; Sayed S Sohrab; Ashraf A Tabll; Ahmed M Hassan; Naoko Iwata-Yoshikawa; Noriyo Nagata; Esam I Azhar
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-26

Review 9.  IgY - turning the page toward passive immunization in COVID-19 infection (Review).

Authors:  Carolina Constantin; Monica Neagu; Teodora Diana Supeanu; Viorica Chiurciu; Demetrios A Spandidos
Journal:  Exp Ther Med       Date:  2020-04-30       Impact factor: 2.447

Review 10.  Advances in the Prophylaxis of Respiratory Infections by the Nasal and the Oromucosal Route: Relevance to the Fight with the SARS-CoV-2 Pandemic.

Authors:  Nadezhda Ivanova; Yoana Sotirova; Georgi Gavrailov; Krastena Nikolova; Velichka Andonova
Journal:  Pharmaceutics       Date:  2022-02-27       Impact factor: 6.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.